+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Clinical Laboratory Tests Market Worth $174.84 Billion in 2019”, says Visiongain report

19 December 2019
Pharma

Visiongain’s new report the Clinical Laboratory Tests Market Report 2019-2029: Forecasts by Type (Medical Microbiology, Clinical Chemistry, Hematology, Cytology, Food Intolerance Test, Human and Tumor Genetics, Drug Abuse Testing, Other Esoteric Tests), by Service Provider (Hospital-Based Laboratories, CROs, Others), plus analysis of leading companies indicates that the global Clinical Laboratory Tests market will attain $363 billion revenue by 2029.

Global Clinical Laboratory Tests market is expected to grow on account of growing geriatric population and it is anticipated that growing investments in target diseases epidemiology such as CVDs and diabetes will further boost market growth over the forecast period. The market is expected to grow at a healthy CAGR of 7.6% over the projected period. Growing unhealthy food consumption coupled with growth in obesity levels has led to the growth of numerous chronic diseases such as heart diseases, diabetes and high blood pressure among others. Also, rising awarenessabout the importance of clinical laboratory tests in the delivery of quality health care among patients and healthcare professionals are some of the factors which are anticipated to fuel the growth of clinical laboratory tests market over the forecast period.

In 2019, hospital-based clinical laboratory tests service providers accounted for the majority of market share, owing to the growing demand for early disease detection in combination with emerging infectious diseases. Hospital-based laboratories provide extensive services ranging from key testing, specialty testing to laboratory management services which is expected to spur the growth of clinical laboratory tests market.

In 2019, North America Clinical Laboratory Tests market accounted for more than 35% of overall market share. Strong economic growth followed by the presence of major diagnostic technologies companies is expected to increase Clinical Laboratory Tests market penetration over the forecast period. Asia Pacific is expected to grow at the highest CAGR owing to the presence of untapped opportunities and growth in scientific research in developing economies like India, Japan, and China. Similar trends will offer lucrative growth for clinical laboratory tests market in coming years.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

Read

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read